InsiderTrades

Form 4 for SPRO Spero Therapeutics, Inc.

Accepted 2022-03-16 00:00:00 ET · period of report 2022-03-14 · accession 0001591986-22-000013 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2022-03-16 2022-03-14 SPRO Aquilo Capital, L.P. 10% P - Purchase $7.63 +23.7K 5.23M +0.5% +$180.9K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, $0.001 par value 2022-03-14 P A 15,702 $7.63 5,223,498 I See footnotes — — (F1) The reporting persons are Aquilo Capital, L.P. (the "Fund"), Aquilo Capital Management, LLC ("Aquilo") and Marc R. Schneidman. Aquilo is the general partner and investment adviser of the Fund and other funds managed by Aquilo that hold securities directly for the benefit of their investors. Aquilo may be deemed to beneficially own such securities indirectly as the investment adviser and general partner of the Fund and affiliated funds, and Mr. Schneidman may be deemed to beneficially own them indirectly as the control person of Aquilo. Each of, Aquilo, the Fund and Mr. Schneidman disclaims beneficial ownership of such securities except to the extent of his or its pecuniary interest therein. (F2) Aquilo Capital, LP only owns 3,439,140 of the 5,223,498 shares deemed to be beneficially owned by Aquilo Capital Management, LLC. Aquilo Capital, LP purchased 15,702 shares in this transaction on 3/14/2022.
2 Common Common Stock, $0.001 par value 2022-03-14 P A 8,006 $7.63 5,231,504 I See Footnotes — — (F1) The reporting persons are Aquilo Capital, L.P. (the "Fund"), Aquilo Capital Management, LLC ("Aquilo") and Marc R. Schneidman. Aquilo is the general partner and investment adviser of the Fund and other funds managed by Aquilo that hold securities directly for the benefit of their investors. Aquilo may be deemed to beneficially own such securities indirectly as the investment adviser and general partner of the Fund and affiliated funds, and Mr. Schneidman may be deemed to beneficially own them indirectly as the control person of Aquilo. Each of, Aquilo, the Fund and Mr. Schneidman disclaims beneficial ownership of such securities except to the extent of his or its pecuniary interest therein. (F3) Aquilo Capital, LP only owns 3,439,140 of the 5,231,504 shares deemed to be beneficially owned by Aquilo Capital Management, LLC. Aquilo Capital, LP did not purchase any of the 8,006 shares purchased in this transaction on 03/14/2022.